←back to thread

One universal antiviral to rule them all?

(www.cuimc.columbia.edu)
331 points breve | 1 comments | 26 Aug 25 14:07 UTC | HN request time: 0.2s | source
Show context
ggm ◴[26 Aug 25 21:46 UTC] No.45032720[source]▶
Persisting inflammation is not kind to bodies. All kinds of things could go wrong, and longterm consequences are easy to hypothesise.

Not saying this isn't worth researching but I'd expect big question marks around risk/reward.

replies(3): >>45032879 #>>45032916 #>>45033037 #
1. andrewflnr ◴[26 Aug 25 22:04 UTC] No.45032916[source]▶
I'm guessing the deployment ends up being less mass-population and more "oops, this guy with a viral disease just coughed on me." Though I can easily see long-term, preemptive use being worth the risk for people dealing with, say, ebola patients.